Permanent prostate brachytherapy preplanned technique: The modern Seattle method step-by-step and dosimetric outcomes

Brachytherapy

Volumn 8, Issue 2, 2009, Pages 197-206

  Sylvester, John E ^a   Grimm, Peter D ^a   Eulau, Stephen M ^a   Takamiya, Robert K ^a   Naidoo, Devi ^a  

^a SWEDISH MEDICAL CENTER   (United States)

Author keywords

Brachytherapy; Dosimetry; Preplan technique; Prostate cancer; Radiotherapy; Seattle

Indexed keywords

CESIUM; CESIUM 131; IODINE 125; PALLADIUM 103; UNCLASSIFIED DRUG;

ARTICLE; BRACHYTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSIMETRY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR VOLUME;

BRACHYTHERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; ENDOSONOGRAPHY; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM STAGING; PROSTATIC NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; WASHINGTON;

EID: 65449134261     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2009.02.001     Document Type: Article

References (23)

1. Holm H.H., Juul N., Pedersen J.F., et al. Transperineal 125-iodine seed implantation in prostatic cancer guided by transrectal ultrasonography. J Urol 130 (1983) 283-286
2. Blasko J.C., Radge H., and Schumacher D. Transperineal percutaneous iodine-125 implantation for prostatic carcinoma using transrectal ultrasound and template guidance. Endocuriether Hyperthermia Oncol 3 (1987) 131-139
3. Sylvester J., Blasko J.C., Grimm P., et al. Interstitial implantation techniques in prostate cancer. J Surg Oncol 66 (1997) 65-75
4. Blasko J.C., Grimm P.D., Sylvester J.E., et al. Palladium-103 brachytherapy for prostate carcinoma. Int J Radiat Oncol Biol Phys 46 (2000) 839-850
5. Grimm P., Blasko J., Sylvester J.E., et al. Ten year biochemical (prostate-specific antigen) control of prostate cancer with 125-I brachytherapy. Int J Radiat Oncol Biol Phys 51 (2001) 31-40
6. Sylvester J.E., Blasko J.C., Grimm P.G., et al. Ten year biochemical relapse free survival functions following brachytherapy with external beam radiotherapy for patients with localized prostate cancer: The Seattle experience. Int J Radiat Oncol Biol Phys 57 (2004) 944-952
7. Sylvester J.E., Blasko J.C., Grimm P.D., et al. Long term outcomes of external beam radiation therapy plus prostate brachytherapy. (Abstr.). J Clin Oncol 22 (2004) 4267 ASCO presentation
8. Donohue J.F., Bianco F.J., Kuroiwa K., et al. Poorly differentiated prostate cancer treated with radical prostatectomy: Long-term outcome and incidence of pathological downgrading. J Urol 176 (2006) 991-995
9. Roehl K.A., Han M., Ramos C.G., et al. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: Long-term results. J Urol 172 (2004) 910-914
10. Han M., Partin A.W., Pound C.R., et al. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 28 (2001) 555-565
11. Bastian P.J., Gonzalgo M.L., Aronson W.J., et al. Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10. Cancer 107 (2006) 1265-1272
12. Merrick G.S., Butler W.M., Wallner K.E., et al. Impact of supplemental EBRT and/or AA on biochemical outcome after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 61 (2005) 32-43
13. Zelefsky M.J., Yamada Y., Cohen G.N., et al. Intraoperative real-time planned conformal prostate brachytherapy: Post-implantation dosimetric outcome and clinical implications. Radiother Oncol 84 (2007) 185-189
14. Stock R.G., Stone N.N., Wesson M.F., et al. A modified technique allowing interactive ultrasound-guided three-dimensional transperineal prostate implantation. Int J Radiat Oncol Biol Phys 32 (1995) 219-225
15. Potters L., Calugaru E., Jassal A., et al. Is there a role for postimplant dosimetry after real-time dynamic permanent prostate brachytherapy?. Int J Radiat Oncol Biol Phys 65 (2006) 1014-1019
16. Stock R.G., Stone N.N., Tabert A., et al. A dose-response study for I-125 prostate implants. Int J Radiat Oncol Biol Phys 41 (1998) 101-108
17. Potters L., Cao Y., Calugaru E., et al. A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 50 (2001) 605-614
18. Han B.H., and Wallner K.E. Dosimetric and radiographic correlates to prostate brachytherapy-related rectal complications. Int J Cancer 96 (2001) 372-378
19. Chao K.K., Goldstein N.S., Yan D., et al. Clinicopathologic analysis of extracapsular extension in prostate cancer: Should the clinical target volume be expanded posterolaterally to account for microscopic extension?. Int J Radiat Oncol Biol Phys 65 (2006) 999-1007
20. Sylvester JE. Presented at the 9th Annual Seattle Prostate Institute Prostate Brachytherapy Advanced Users Conference. Seattle, WA. April 2006.
21. Taussky D., Yeung I., Williams T., et al. Rectal wall dose dependence on postplan timing after permanent-seed prostate brachytherapy. Int J Radiat Oncol Biol Phys 65 (2006) 358-363
22. Waterman F., and Dicker A. Probability of late rectal morbidity in I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys 55 (2003) 342-353
23. Cesaretti A., Stock R., Atencio D., et al. A genetically determined dose-volume histogram predicts for rectal bleeding among patients treated with prostate brachytherapy. Int J Radiat Oncol Biol Phys 68 (2007) 1410-1416